Brevan Howard Capital Management’s Healthcare Realty HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$468K Sell
23,206
-136
-0.6% -$2.64K ﹤0.01% 1484
2026
Q1
$397K Buy
+23,342
New +$409K ﹤0.01% 1439
2025
Q4
– Sell
-10,800
Closed -$195K – 2018
2025
Q3
$195K Sell
10,800
-49,506
-82% -$837K ﹤0.01% 1761
2025
Q2
$956K Buy
+60,306
New +$917K 0.01% 1085
2025
Q1
– Sell
-37,644
Closed -$638K – 1286
2024
Q4
$638K Sell
37,644
-15,034
-29% -$264K ﹤0.01% 551
2024
Q3
$956K Buy
52,678
+11,100
+27% +$197K 0.01% 469
2024
Q2
$685K Buy
41,578
+3,326
+9% +$50.9K 0.01% 510
2024
Q1
$541K Sell
38,252
-16,350
-30% -$247K ﹤0.01% 434
2023
Q4
$941K Buy
54,602
+34,194
+168% +$522K 0.01% 252
2023
Q3
$312K Buy
+20,408
New +$362K ﹤0.01% 235

Other funds holding HR

Brevan Howard Capital Management's HR Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Healthcare Realty (HR) stake by 0.58% in Q2 2026, selling an estimated $2.64K and leaving 23,206 shares worth $468K. The position accounts for ﹤0.01% of the portfolio, ranked #1484.

Brevan Howard Capital Management first reported a position in HR in Q3 2023 and has held it in 10 quarters since. The position peaked at $956K in Q2 2025. 462 funds tracked by Wall St. Rank hold HR as of Q2 2026.

  • Brevan Howard Capital Management held 23,206 shares of Healthcare Realty worth $468K as of Q2 2026.
  • Brevan Howard Capital Management sold 136 Healthcare Realty shares in Q2 2026, an estimated $2.64K.
  • Healthcare Realty made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1484 holding.
  • Brevan Howard Capital Management first reported a position in Healthcare Realty in Q3 2023 and has held it in 10 quarters since.
  • Brevan Howard Capital Management's Healthcare Realty position peaked at $956K in Q2 2025.
  • 462 funds tracked by Wall St. Rank held Healthcare Realty as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.